Skip to content

Medpace Holdings, Inc. MEDP Accrued Manufacturing Costs

Accrued Manufacturing Costs at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Tenet Healthcare logo
Tenet HealthcareTHC
Veeva Systems logo
Veeva SystemsVEEV
Arrowhead Research logo
Arrowhead ResearchARWR
BridgeBio Pharma logo
BridgeBio PharmaBBIO
SS&C Technologies logo
SS&C TechnologiesSSNC

Other financials

Income statement

See full
Revenue$706.6M+26.5%
Operating income$141.5M+24.6%
Net income$123.9M+8.1%
EPS (diluted)$4.28+16.6%

Balance sheet

See full
Cash & equivalents$652.7M+47.9%
Total debt$146.1M-2.8%
Total equity$598.3M+0.8%
Total assets$2.1B+12.2%

Cash flow

See full
Operating cash flow$151.8M+20.6%
CapEx$6.8M-31.8%
Free cash flow$145.0M+25.1%

Valuation

See full
Market cap$13.14B+46.8%
Enterprise value$12.64B+45.9%
P/E28.6×+7.0×
P/S4.9×+0.8×

Profitability

See full
Operating margin21%-0.1pp
Net margin17.2%-2.1pp
FCF margin26.5%+1.5pp

Returns & leverage

See full
Return on equity77.3%+11.4pp
Debt / equity0.2×0.0×
Current ratio0.8×+0.1×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medpace Holdings, Inc.'s accrued manufacturing costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medpace Holdings, Inc.'s accrued manufacturing costs?
Medpace Holdings, Inc. (MEDP) reported accrued manufacturing costs of $61.6M in Q1 2026.
How has Medpace Holdings, Inc.'s accrued manufacturing costs changed year-over-year?
Medpace Holdings, Inc.'s accrued manufacturing costs increased by 15.8% year-over-year, from $53.19M to $61.6M.
What is the long-term trend for Medpace Holdings, Inc.'s accrued manufacturing costs?
Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s accrued manufacturing costs has grown at a 8.5% compound annual growth rate (CAGR), from $57.85M to $80.14M.